Literature DB >> 16821440

[Dépistage de l'épilepsie en zones tropicales: validation d'un questionnaire en Mauritanie].

M Diagana1, P M Preux, M Tuillas, A Ould Hamady, M Druet-Cabanac.   

Abstract

Prevalence of epilepsy in developing countries is considered to be 2 to 5 times superior to the industrialized countries. In tropical areas, the diagnosis of epilepsy is still reliant on the clinic and requires a precise semiological description. A good epidemiological and clinical research requires standardized and validated screening tools. The objective of this work was to evaluate the validity of the screening module of the investigation questionnaire on epilepsy in tropical areas, in Nouakchott, Mauritania. All the patients included in the study were examined at first by a neurologist, then directed towards an investigator who asked the 5 screening items of the investigation questionnaire. Any person answering "yes" at least one question was regarded as "suspected of epilepsy" by the investigator. Secondly the neurologist re-examined the subjects and confirmed the diagnosis. The sensitivity and the specificity of the module of screening were calculated. On the whole, 236 patients were included in the study 131 had answered "yes" at least one of the questions of the module of screening and was regarded as "suspected" of epilepsy (55.5%) by the questionnaire. The diagnosis of epilepsy was made for 82 subjects by the neurologist. The sensitivity of the module of screening of the epilepsy was 95.1% (CI 95%: 87.3-98.4) and specificity was 65.6% (CI 95%: 57.5-72.9). The screening module of the investigation questionnaire of epilepsy in tropical zones, made up only by 5 questions, has diagnosis qualities acceptable and comparable with those reported in the literature. The use of this tool integrated in a more general questionnaire of investigation of the. epilepsy proves to be an essential instrument in conducting epidemiologic studies in epileptology' in tropical zones.

Entities:  

Mesh:

Year:  2006        PMID: 16821440

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  19 in total

1.  High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.

Authors:  Bethany Levick; Anne Laudisoit; Floribert Tepage; Chellafe Ensoy-Musoro; Michel Mandro; Caroline Bonareri Osoro; Patrick Suykerbuyk; Jean Marie Kashama; Michel Komba; Alliance Tagoto; Dadi Falay; Michael Begon; Robert Colebunders
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

2.  A screening questionnaire for convulsive seizures: A three-stage field-validation in rural Bolivia.

Authors:  Loretta Giuliano; Calogero Edoardo Cicero; Elizabeth Blanca Crespo Gómez; Sandra Padilla; Elisa Bruno; Mario Camargo; Benoit Marin; Vito Sofia; Pierre-Marie Preux; Marianne Strohmeyer; Alessandro Bartoloni; Alessandra Nicoletti
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

3.  High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.

Authors:  Bruno P Mmbando; Patrick Suykerbuyk; Mohamed Mnacho; Advocatus Kakorozya; William Matuja; Adam Hendy; Helena Greter; Williams H Makunde; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2018-06-20       Impact factor: 4.520

4.  The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol.

Authors:  Gasim Abd-Elfarag; Makoy Yibi Logora; Jane Y Carter; Morrish Ojok; Jackson Songok; Sonia Menon; Ferdinand Wit; Richard Lako; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2018-11-14       Impact factor: 4.520

5.  High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo.

Authors:  Evy Lenaerts; Michel Mandro; Deby Mukendi; Patrick Suykerbuyk; Housseini Dolo; Deogratias Wonya'Rossi; Françoise Ngave; Chellafe Ensoy-Musoro; Anne Laudisoit; An Hotterbeekx; Robert Colebunders
Journal:  Infect Dis Poverty       Date:  2018-08-01       Impact factor: 4.520

6.  The Impact of Pediatric Epilepsy on Children and Families: A Multicenter Cross-Sectional Study.

Authors:  Ahmed Hussein Subki; Abdel Moniem Mukhtar; Rakan Salah Al-Harbi; Abdulaziz Khaled Alotaibi; Faisal Ghazi Mosaad; Mohammed Saad Alsallum; Mohammed M S Jan
Journal:  Clin Pract Epidemiol Ment Health       Date:  2018-12-31

7.  Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.

Authors:  Joseph Nelson Siewe Fodjo; Godwin Tatah; Earnest Njih Tabah; Leonard Ngarka; Leonard Njamnshi Nfor; Samuel Eric Chokote; Michel K Mengnjo; Fidèle Dema; Aurélien Tele Sitouok; Grace Nkoro; Félicien E Ntone; Anne-Cécile Zoung-Kanyi Bissek; Cédric B Chesnais; Michel Boussinesq; Robert Colebunders; Alfred K Njamnshi
Journal:  Infect Dis Poverty       Date:  2018-12-03       Impact factor: 4.520

8.  High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment.

Authors:  Deby Mukendi; Floribert Tepage; Innocent Akonda; Joseph Nelson Fodjo Siewe; Anke Rotsaert; Carl Nwana Ndibmun; Anne Laudisoit; Simon Couvreur; Blandine Kabutako; Sonia Menon; An Hotterbeekx; Robert Colebunders
Journal:  Int J Infect Dis       Date:  2019-02       Impact factor: 3.623

9.  High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey.

Authors:  Stephen Raimon; Alfred Dusabimana; Gasim Abd-Elfarag; Samuel Okaro; Jane Y Carter; Charles R Newton; Makoy Yibi Logora; Robert Colebunders
Journal:  Pathogens       Date:  2021-05-14

10.  Evolution of epilepsy prevalence and incidence in a Tanzanian area endemic for onchocerciasis and the potential impact of community-directed treatment with ivermectin: a cross-sectional study and comparison over 28 years.

Authors:  Helena Greter; Bruno Mmbando; Williams Makunde; Mohamed Mnacho; William Matuja; Advocatus Kakorozya; Patrick Suykerbuyk; Robert Colebunders
Journal:  BMJ Open       Date:  2018-03-31       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.